Adhera Therapeutics Stock Fundamentals
ATRXDelisted Stock | USD 0.72 0.00 0.00% |
Adhera Therapeutics fundamentals help investors to digest information that contributes to Adhera Therapeutics' financial success or failures. It also enables traders to predict the movement of Adhera Pink Sheet. The fundamental analysis module provides a way to measure Adhera Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adhera Therapeutics pink sheet.
Adhera |
Adhera Therapeutics Company Number Of Shares Shorted Analysis
Adhera Therapeutics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Adhera Therapeutics Number Of Shares Shorted | 2.05 K |
Most of Adhera Therapeutics' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adhera Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Adhera Therapeutics has 2.05 K of outstending shares currently sold short by investors. This is 99.94% lower than that of the Biotechnology sector and 99.96% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.96% higher than that of the company.
Adhera Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adhera Therapeutics's current stock value. Our valuation model uses many indicators to compare Adhera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adhera Therapeutics competition to find correlations between indicators driving Adhera Therapeutics's intrinsic value. More Info.Adhera Therapeutics is rated fifth in return on asset category among its peers. It is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adhera Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adhera Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Adhera Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adhera Therapeutics' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Adhera Therapeutics could also be used in its relative valuation, which is a method of valuing Adhera Therapeutics by comparing valuation metrics of similar companies.Adhera Therapeutics is currently under evaluation in number of shares shorted category among its peers.
Adhera Fundamentals
Return On Asset | -4.48 | ||||
Current Valuation | 10.55 M | ||||
Shares Outstanding | 3.16 M | ||||
Shares Owned By Insiders | 21.87 % | ||||
Number Of Shares Shorted | 2.05 K | ||||
Price To Earning | (125.83) X | ||||
Price To Sales | 8.23 X | ||||
Gross Profit | (157 K) | ||||
EBITDA | (4.92 M) | ||||
Net Income | (6.35 M) | ||||
Cash And Equivalents | 849 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 7.35 M | ||||
Debt To Equity | 56.30 % | ||||
Current Ratio | 0.05 X | ||||
Book Value Per Share | (6.90) X | ||||
Cash Flow From Operations | (665 K) | ||||
Short Ratio | 3.24 X | ||||
Earnings Per Share | (0.52) X | ||||
Number Of Employees | 12 | ||||
Beta | -0.14 | ||||
Market Capitalization | 2.18 M | ||||
Total Asset | 196 K | ||||
Retained Earnings | (42.43 M) | ||||
Working Capital | 16.49 M | ||||
Current Asset | 20.36 M | ||||
Current Liabilities | 3.88 M | ||||
Net Asset | 196 K |
About Adhera Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adhera Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adhera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adhera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Adhera Pink Sheet
If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |